Savant Explorations (SVATF) 0.0150 $SVATF Savant

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Savant Explorations (SVATF) 0.0150 $SVATF

Savant Appoints Chief Financial Officer
Marketwired - Thu Jun 02, 7:31AM CDT
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 2, 2016) - Savant Explorations Ltd. (TSX VENTURE:SVT) ("Savant" or "the Company" is pleased to announce the appointment of Thomas Herdman as Chief Financial Officer. Mr. Herdman replaces Reg Advocaat who has been acting as Interim CFO. Mr. Advocaat remains as a Director of the Company.
SVT.VN: 0.015 (unch), IBM: 160.04 (-1.32)

Yuby-Gabriela Copper Property Returned to Savant
Marketwired - Mon Nov 30, 7:31AM CST
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" has received notice from Quantum Pacific Exploration of its intent to terminate the option agreement on Savant's wholly-owned Yuby-Gabriela copper porphyry property in Chile. With termination of the option, Savant retains a 100% ownership interest in the property. Savant will now undertake a detailed review of the property data to determine the best way to advance the project.
SVT.VN: 0.015 (unch)

Savant Provides a Corporate and Property Update
Marketwired - Mon Oct 05, 7:03AM CDT
Savant Explorations Ltd. (TSX VENTURE: SVT) ("the Company" or "Savant" provides a Corporate and Property Update.
SVT.VN: 0.015 (unch)

Savant Explorations Ltd. Announces Board Changes and Granting of Options
Marketwired - Wed Jun 24, 7:02AM CDT
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" is pleased to announce that Mr. Rupert Legge has been appointed to the Board. Mr. Legge is a retired business executive and the former Executive Vice-President, Legal and Corporate Secretary for Alterra Power Corporation.
SVT.VN: 0.015 (unch)

Savant Provides an Update on Its Exploration Activities and 2015 Plans
Marketwired - Wed Apr 29, 7:31AM CDT
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" provides an update on its exploration programs and 2015 plans.
SVT.VN: 0.015 (unch)

Savant Provides an Overview of its Wholly-Owned Polymetallic Zinc-Copper-Silver Resource Project
Marketwired - Mon Dec 01, 7:32AM CST
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" is currently reviewing various strategic options to advance its wholly-owned Blue Moon zinc-copper-silver advanced resource project, located in Mariposa County, California. The Blue Moon deposit contains a polymetallic massive sulphide resource prepared under NI 43-101 guidelines in excess of 3 million tons with a grade of 5.63% zinc and also containing significant bi-products of copper, silver and gold in the indicated category and 3.1 million tons with a grade of 5.58% zinc and significant bi-products of copper, silver and gold in the inferred category.
SVT.VN: 0.015 (unch)

Savant Provides an Update on Its Exploration Activities
Marketwired - Mon Nov 03, 7:32AM CST
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" provides an update on its Southwest U.S. copper exploration programs.
SVT.VN: 0.015 (unch)

Savant Options Yuby-Gabriela Property to Quantum Pacific
Marketwired - Wed Oct 29, 7:32AM CDT
Savant Explorations Ltd. (TSX VENTURE: SVT) ("Savant" is pleased to announce the signing of an Option Agreement (the "Agreement" with Quantum Pacific Exploration SpA (Quantum Pacific), a private Chilean Company on Savant's wholly-owned Yuby-Gabriela Property, Chile (the "Property".
SVT.VN: 0.015 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading